Skip to content

EPS (Diluted) at other companies

Abbott logo
AbbottABT
$0.61-19.7%
DexCom logo
DexComDXCM
$0.51+88.9%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$0.30+84.8%
AdaptHealth logo
AdaptHealthAHCO
-$0.12-140%
CTS Corporation logo
CTS CorporationCTS
$0.59+34.1%

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Reported directly by Senseonics Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's EPS (diluted)?
Senseonics Holdings, Inc. (SENS) reported EPS (diluted) of -$0.71 in Q1 2026.
How has Senseonics Holdings, Inc. 's EPS (diluted) changed year-over-year?
Senseonics Holdings, Inc. 's EPS (diluted) decreased by 77.5% year-over-year, from -$0.40 to -$0.71.
What is the long-term trend for Senseonics Holdings, Inc. 's EPS (diluted)?
Over 3 years (2022 to 2025), Senseonics Holdings, Inc. 's EPS (diluted) has grown at a 87.6% compound annual growth rate (CAGR), from -$0.20 to -$1.32.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.